Clinical Trial Data Sharing – serie

Breakthrough Business Models

Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

Prevention and Treatment of Missing Data in Clinical Trials

Implementing a National Cancer Clinical Trials System for the 21st Century

Workshop Summary

Developing a National Registry of Pharmacologic and Biologic Clinical Trials

Workshop Report

Challenges for the FDA

The Future of Drug Safety: Workshop Summary

Envisioning a Transformed Clinical Trials Enterprise in the United States

Establishing an Agenda for 2020: Workshop Summary

Sharing Clinical Research Data

Workshop Summary

Envisioning a Transformed Clinical Trials Enterprise for 2030

Proceedings of a Workshop

Implementing a National Cancer Clinical Trials System for the 21st Century

Second Workshop Summary

Large Simple Trials and Knowledge Generation in a Learning Health System

Workshop Summary

Discussion Framework for Clinical Trial Data Sharing

Guiding Principles, Elements, and Activities

Sharing Clinical Trial Data

Maximizing Benefits, Minimizing Risk

Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies

Workshop Summary

Ovarian Cancers

Evolving Paradigms in Research and Care

Biomarker Tests for Molecularly Targeted Therapies

Key to Unlocking Precision Medicine

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

Proceedings of a Workshop

Drug Development Paradigm in Oncology

Proceedings of a Workshop

Implementing and Evaluating Genomic Screening Programs in Health Care Systems

Proceedings of a Workshop